Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Allogene Therapeutics (ALLO) Times Interest Earned (2024 - 2025)

Allogene Therapeutics' Times Interest Earned history spans 2 years, with the latest figure at -$130.53 for Q3 2025.

  • For Q3 2025, Times Interest Earned rose 81.81% year-over-year to -$130.53; the TTM value through Sep 2025 reached -$269.75, up 90.94%, while the annual FY2024 figure was -$1509.4, N/A changed from the prior year.
  • Times Interest Earned for Q3 2025 was -$130.53 at Allogene Therapeutics, up from -$212.01 in the prior quarter.
  • Across five years, Times Interest Earned topped out at -$130.53 in Q3 2025 and bottomed at -$746.79 in Q4 2024.